Robbins Farley’s Axcelis ACLS Stock Holding History

Robbins Farley’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37	Closed	-$4.93K	–	162
2023 Q1	$4.93K	Hold	37	–	–	﹤0.01%	135
2022 Q4	$2.94K	Buy	+37	New	+$2.61K	﹤0.01%	130

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Robbins Farley's ACLS Position: Q2 2023 in Review

Robbins Farley sold out of Axcelis (ACLS) in Q2 2023, closing a stake of 37 shares — an estimated $4.93K sold.

Robbins Farley first reported a position in ACLS in Q4 2022 and held it in 2 quarters. The position peaked at $4.93K in Q1 2023. 405 funds tracked by Wall St. Rank hold ACLS as of Q2 2023.

Robbins Farley reported no remaining Axcelis position as of Q2 2023 after selling out during the quarter.
Robbins Farley sold 37 Axcelis shares in Q2 2023, an estimated $4.93K.
Robbins Farley first reported a position in Axcelis in Q4 2022 and held it in 2 quarters.
Robbins Farley's Axcelis position peaked at $4.93K in Q1 2023.
405 funds tracked by Wall St. Rank held Axcelis as of Q2 2023.

Based on Robbins Farley's 13F filing for Q2 2023, filed 7 Aug 2023.